CURRENT ROADSHOWS

LATEST NEWS

Generex Biotechnology Subsidiaries NuGenerex Immuno-Oncology and NuGenerex Diagnostics Working to Address...

NuGenerex Immuno-Oncology’s Ii-Key technology is clinically proven to activate the immune system against numerous viruses including H5N1 avian influenza virus Ii-Key peptide vaccines offer...

Generex Biotechnology Provides 2019 Year-End Summary & 2020 Plans

MIRAMAR, Fla., Jan. 16, 2020 (GLOBE NEWSWIRE) -- Generex Biotechnology Corporation (www.generex.com) (OTCQB:GNBT) (http://www.otcmarkets.com/stock/GNBT/quote) is happy to provide the investment community with a review...
Advertisement

LATEST INTERVIEWS

CEORoadshow Interview with David Rowe, Founder & CEO of Hydro66 (HYHDF)

In this episode of CEORoadshow, we are joined by Mr. David Rowe, Founder & CEO of Hydro66 Holdings. Hydro66 owns and operates an award-winning colocation...

CEORoadshow Interview with Darren Jamison, President & CEO of Capstone Turbine...

In this episode of CEORoadshow, we are joined by Mr. Darren Jamison President & CEO of Capstone Turbine, the world's leading clean technology manufacturer...
381cf01438895cab0b3756fba2d0131142708ac5e7aa3f1832